Table 3. Associations between various demographic and laboratory factors and DPP4a.

	Β	95% CI	p
Age	−0.10	(−0.18, −0.02)	0.01
Fibrinogen	−1.27	(−2.12, −0.43)	<0.01
Peak CK-MB	0.01	(0.006, 0.02)	<0.01
GGT	0.04	(0.02, 0.06)	<0.01

B-coefficients and 95% CI meant the unstandardized coefficients and their 95% confidence interval. The following variables were removed from the model: gender, body mass index (BMI), total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, peak myoglobin, peak cardiac troponin (cTNT), fasting plasma glucose, thrombin time, prothrombin time, activated partial thromboplastin time (APTT), D-dimers, pro-brain natriuretic peptide (pro-BNP), creatinine, history of hypertension, previous myocardial infarction (MI), smoking status, use of an angiotensin-converting-enzyme inhibitor (ACEI) or an angiotensin receptor blocker (ARB), statin use, aspirin use, β-blocker use, and aldosterone antagonist use.

CK-MB, MB isoenzyme of creatine kinase; DPP4a, plasma dipeptidyl peptidase-4 activity; GGT, gamma-glutamyltransferase.